In patients with type 1 diabetes (T1D) that have undergone islet of Langerhans transplantation or are on the waiting list for transplantation, Ga-68-exendin PET imaging is performed to study the visualization of transplanted islet grafts in patients.
Detecting damage to islets with a reliable imaging technique could be important for improving islet survival after transplantation. This could lead to better patient outcomes which would be of great interest for the treatment of type 1 diabetes. In order to assess the possibility of visualizing transplanted islet grafts with Ga-68-NODAGA-exendin-4 PET, a proof-of -concept study is performed in 10 patients with type 1 diabetes who have undergone intrahepatic islet transplantation with biochemically proven functional islet grafts and 5 patients with type 1 diabetes who are on the waiting list for islet transplantation. The investigators propose to determine the uptake of the radiolabeled tracer and compare it to functionality of the islet grafts. These highly relevant data will provide us with more information on the suitability of GLP-1 receptor imaging for monitoring of transplanted islet mass.
Study Type
OBSERVATIONAL
Enrollment
13
68Ga-NODAGA-exendin PET/CT
Radboud university medical center
Nijmegen, Gelderland, Netherlands
Uppsala University Hospital
Uppsala, Sweden
Hepatic uptake of 68Ga-NODAGA-exendin-4
Hepatic uptake of 68Ga-NODAGA-exendin-4 obtained by quantitative analysis
Time frame: 1 year
Islet graft function
Correlation of tracer uptake and islet graft function
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.